Oriola

ORIOLA · Nasdaq Helsinki · Healthcare

0.81EUR −1.2%last day

Price as of 2 October 2026

The price over the past year, with dividends: −26.9%

Performance

1 month

−9.8%

1 year

−26.9%

3 years, per year

+2.2%

5 years, per year

−10.5%

Largest fall, 3 years

−58.6%

Below the peak now

−73.7%

Volatility, 1 year

21.7%

Return with dividends reinvested.

Key figures

P/E

negative earnings

P/B

1.7

Dividend yield

3.7%

Return on equity

−22.2%

Net margin

−1.8%

Market value

170 m USD

Quality, value and trend

Where Oriola stands against every Nordic stock today. 100 is best.

Quality3

Profitability and a sound balance sheet over time. Better than 3% of Nordic stocks.

Value26

The price measured against earnings, assets and cash flow. Better than 26% of Nordic stocks.

Trend17

The price development over the past year. Better than 17% of Nordic stocks.

Combined2

Quality, value and trend together. Better than 2% of Nordic stocks.

About Oriola

Oriola is a company in healthcare, listed on Nasdaq Helsinki. The share trades in EUR. It has around 800 employees.

Oriola Oyj engages in the wholesale of pharmaceuticals and health products in Sweden, Finland, and internationally. The company distributes vitamins, food and food supplements, sports nutrients, wound care, beauty, and makeup related products; vaccines; and over-the-counter products. In addition, it provides pharmaceutical logistics; special licensed medicine importing, dose dispensing, and research pharmacy services; and commercial data, clinical trial, regulatory affairs and quality, medical and scientific affairs, market access and tenders, real world evidence, sales support, medical translation, pharmacovigilance and medical information, and patient support services.

See the full analysis in InvestWiser.

The accounts, dividends, 40 years of charts and the comparison with other stocks are in the app.

See the full analysis